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Reviews
Primary hyperparathyroidism may have a hetero-
genous aetiology and pathogenesis, and the optional
therapy must be individualized for patients1 with the
following: 1) single-gland disease (adenoma), 2)
hyperplasia of four or more glands, 3) double adenoma,
4) carcinoma, 5) microadenoma, 6) disrupted parathyroid
syndrome, and 7) normal pathology.
The best surgical strategy enables the primary
hyperparathyroidism to be resolved with minimal
complications,2 such as persistent hyperparathyroidism,
recurrent hyperparathyroidism, postoperative
hypoparathyroidism, and recurrent laryngeal nerve injury.
The surgical strategy must also minimize the length and
region of incision, extent of exploration, cost and length
of hospital stay, while maintaining an excellent outcome.
The success rate for parathyroidectomies performed
by experienced endocrine surgeons is 95% or better.3,4
Persistent hyperparathyroidism is usually the result of
missing either an ectopic tumour or one of multiple
abnormal glands. Recurrent hyperparathyroidism usually
occurs in patients with familial disease, such as those with
familial isolated hyperparathyroidism and multiple endo-
crine neoplasia (MEN) 1. Until recently, an argument
existed as to whether unilateral or bilateral neck explora-
tion was preferable for primary hyperparathyroidism.
Surgeons who advocated bilateral neck exploration be-
lieved that it should be the standard approach because it
is safe and greatly reduces the chances of missing a
second adenoma. Innovations such as the intraoperative
quick parathyroid hormone (PTH) assay and sestamibi
scintigraphy have allowed the development of radio-
guided, endoscopic parathyroidectomies, which are both
minimally invasive and precise. Several investigators
have reported high success rates using these techniques,
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More than 95% of patients with primary hyperparathyroidism have been treated with bilateral neck
exploration by experienced surgeons. This procedure has been performed without employing preoperative
localization tests or specialized techniques of intraoperative measurement. A renewed interest in
unilateral neck exploration for primary hyperparathyroidism emerged (in three developments), in an
attempt to maintain the excellent cure rate and to minimize the invasiveness of the procedure. The first
development was the introduction of sestamibi scintigrams as a new preoperative localization
technique and intraoperative nuclear mapping with a hand-held gamma probe. The localization of
adenomas using this technique was much more accurate than that of previous localization studies,
allowing unilateral procedures to become feasible. Sestamibi guidance enables parathyroidectomies to
be performed much more rapidly through a significantly less invasive dissection. Secondly, the
intraoperative quick parathyroid hormone assay allows the confirmation of removal of the parathyroid
mass. The third development was endoscopic parathyroidectomy. Various approaches have been
shown to be technically feasible, including endoscopic procedures that rely on CO2 insufflation to
create a working space or video-assisted procedures in which the working space is maintained through
conventional external retraction. Given the safety and high success rate of the standard exploration,
the potential advantages of these new strategies include decreased operating time, local or regional
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with reductions in incision length, operation time, and
length of hospital stay.
 UNILATERAL NECK EXPLORATION
The success of bilateral neck explorations with or
without the biopsy of normal-looking glands depends on
the surgeon’s ability to differentiate between normal and
abnormal glands on the basis of size. In experienced
hands, this approach results in a 90% to 98% success rate
with low morbidity.5 Some surgeons have performed
unilateral neck exploration if only one enlarged gland and
an ipsilateral gland of normal size were found.6
Experienced endocrine surgeons have reported excellent
results using this limited surgical approach. In the 1990s,
the availability of sestamibi and ultrasonography (US)
greatly facilitated surgical policies regarding unilateral
neck exploration.7,8 In 1995 and 1996, the author
performed unilateral neck exploration in all 33 of his
patients with solitary parathyroid adenomas.8 Double-
phase MIBI-99m Tc subtraction scintigraphy, alone or
with single photon emission computed tomography, was
performed in combination with US in each case.9 The
sensitivity of the MIBI scintigraphy and US were 92% and
86%, respectively. All of the patients were successfully
treated using a unilateral approach except for two patients
in whom a solitary adenoma was detected in the
mediastinum. The average operating time, excluding the
two cases requiring a mediastinectomy, was 41 minutes.
No complication occurred in any of the patients. Although
the surgical success rate is influenced by the length of the
follow-up period, the success rate in this group, to date, is
100%. Thanks to techniques that allow proper localization,
the unilateral approach for patients with primary
hyperparathyroidism is less invasive, associated with
fewer complications, and can be tolerated by most patients
with primary hyperparathyroidism.10 For patients at high
risk, such as those with respiratory or cardiovascular diseases,
unilateral exploration under local anaesthesia is a useful
method of treatment. A retrospective study found no differ-
ences in the surgical outcome between unilateral explora-
tion and bilateral exploration.2 One might, thus, argue that
unilateral exploration is, at the very least, not worse than
bilateral exploration. The frequency of persistent hyperpar-
athyroidism was 5% higher for unilateral exploration than
that for bilateral exploration. Since a prospective, controlled
study has not been performed, the argument for or against
unilateral neck exploration remains theoretical.
MINIMALLY INVASIVE PARATHYROIDECTOMY
Sestamibi scintigraphy is a new technique that enables
the accurate localization of parathyroid adenomas. Using
this modality, a new procedure known as radio-
guided parathyroidectomy has been developed.11 The
combintaion of this procedure with the use of the
intraoperative quick PTH, which provides biochemical
confirmation that the adenomas have been completely
excised, could revolutionize the new approach for
parathyroidectomies.12 In addition, the development of
endoscopic parathyroidectomies has also been an
evolutionary change in surgical procedures for parathy-
roidectomies.13–15
The recent  development  of  radio-guided
parathyroidectomy has allowed parathyroidectomies to
be quickly performed using a significantly less invasive
procedure.11 Radio-guided parathyroidectomy is also
likely to decrease the risk of nerve injury because of the
minimal amount of dissection required and the directed
nature of the technique. A smaller operative region is also
likely to be associated with a smaller risk of hematoma
formation and a reduced need for drainage. Although
radio-guided parathyroidectomy is a viable alternative to
standard surgery for properly selected hyperparathyroid
patients with no history of exploratory procedures in the
neck region, it is also extremely useful in patients with
hyperparathyroidism who have undergone previous neck
exploratory procedures. The advantages of this procedure
include a smaller incision, a shorter operation time, a
decreased risk of complications, discharge from the
hospital two hours after surgery, the near-elimination of
the need for frozen section histological analysis, and a less
complicated preoperative work-up.
Irvin et al have developed a quick assay for determining
PTH levels.12 The assay can be used intraoperatively
during neck exploration. Several recent reports have
confirmed the accuracy and utility of this approach.13 The
quick PTH assay is commonly performed by obtaining a
baseline PTH level and then testing the PTH levels at 5 and
10 minutes after the resection of the putative parathyroid
tissue. A 50% decrease in the PTH level measured 5
minutes after removal of the parathyroid tissue is indicative
of a cure.12 Weber and Ritchie reported that intraoperative
PTH monitoring can accurately predict the outcome of
parathyroid surgery in patients with solitary adenomas,16
but that this assay may underestimate the extent of resec-
tion required in patients with parathyroid hyperplasia.
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When compared to parathyroidectomies guided by the
appearance of abnormal parathyroid gland morphology,
the intraoperative quick PTH assay can accurately predict
the disease state in 89% of patients.17 In addition to a
shorter operating time and associated morbidity, directed
parathyroidectomy also has the potential to realize
significant cost reductions. The intraoperative PTH assay
may be particularly useful in complicated cases and in
patients undergoing a second operation. This test does,
however, have some limitations and should not be used
as a substitute for a thorough knowledge of the wide
spectrum of potential findings that can occur during
operations for hyperparathyroidism.18 To evaluate the
possible risk of recurrent or persistent hyperparathyroidism
in cases of false-positive results, further studies are
necessary.
During the last three years, several minimally invasive
parathyroidectomy procedures have been developed for
the treatment of hyperparathyroidism. They range from
the “pure” endoscopic approach (completely closed
technique)19–21 characterized by a constant gas insufflation,
to “video-assisted gasless” techniques22 and minimally
invasive “open” parathyroidectomies guided either by
intraoperative radioisotopes11 or relying on preoperative
localization studies.23 The presently reported procedure
can be classified as a minimal-access surgery and provides
both a better cosmetic scar and a less painful postoperative
course. Its disadvantages include a longer operating time,
a supposedly higher cost, and the possible risk of missing
multiglandular disease. Initial reports on endoscopic and
video-assisted unilateral parathyroidectomies state that
these procedures are useful in cases of localized single
gland disease with no evidence of nodular goitre or
history of prior neck exploration.23 Endoscopic and video-
assisted techniques are, thus, highly feasible. Inaccurate
localization, limited working space, larger parathyroid
adenomas, nodular goitre or prior thyroid surgery
complicate or eliminate the usefulness of these new
techniques. Our successful use of video-assisted
parathyroidectomies using gas insufflation to perform
bilateral parathyroidectomies and subtotal thyroidectomies
led us to reconsider our strategy for operating on thyroid
lesions and multiple parathyroid masses (Figures 1, 2).
Thus, we developed a new technique involving the
performance of an endoscopic parathyroidectomy from
an axillary approach, with no scarring of the neck or
anterior chest wall. In this approach, three trocars are
inserted from the axilla, allowing neck incisions to be
avoided.20 The small scar left in the axilla is completely
covered by the patient’s arm when the arm is in a natural
position.21,24 The cosmetic results are excellent. Sufficient
separation from the axilla to the neck is easily achieved by
gradual CO2 insufflation. The small working space that is
created by maintaining CO2 insufflation at below 4 mmHg
reduces the risk for hypercapnia and subcutaneous
emphysema. Hyperaesthesia and paraesthesia of the neck
are also negligible because of the small subplatysmal
space. Some of the limitations of exposure, visualization,
dissection, and haemostasis that presently confound the
endoscopic approach should be overcome by further
technological advances in minimally invasive
Figure 1. After making a 5-mm median skin incision for
insertion of a laparoscope, two additional 5-mm trocars are
inserted into the subcutaneous tissue about 5 cm below the
inferior border of the ipsilateral clavicle. The specimen is placed
in a finger of a plastic glove, and extracted through the 5-mm
skin incision.
Figure 2. The right inferior parathyroid adenoma is pro-
truded to separate the thymus tissue and dissected with endo-
scopic scissors.
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instrumentation.25 Although the merits and disadvantages
of endoscopic or video-assisted parathyroidectomy and
radio-guided parathyroidectomy must be evaluated on a
broader scale, it is likely that minimally invasive techniques
for neck exploration and parathyroidectomy will play an
increasingly important role in the management of patients
with hyperparathyroidism.
The new technique introduced here is apt to lead to
shorter hospital stays in a select group of patients, as this
operative procedure may be performed on an outpatient
basis. Due to the different insurance systems
internationally, information on the length of overall hospital
stay is not comparable between countries.
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